David Michael Johnson Insider Profile

11 Followers
David Michael Johnson, Director at Zentalis Pharmaceuticals, holds 435.84K shares in Aura Biosciences Inc (Ticker: AURA), holds 192.82K shares in Zentalis Pharmaceuticals (Ticker: ZNTL).
tipranks
David Michael Johnson

David Michael Johnson
Zentalis Pharmaceuticals (ZNTL)
Director

Ranked #72,825 out of 99,218 Corporate Insiders

Profitable Transactions

14%
1 out of 7 Profitable Transactions

Average Return

-11.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$6M
86.13%
13.87%
A breakdown of David Michael Johnson's holdings

Insider Roles

Aura Biosciences Inc
(AURA)
Director
Zentalis Pharmaceuticals
(ZNTL)
Director
Roles that David Michael Johnson holds in companies

Most Profitable Insider Trade

Stock:
Aura Biosciences Inc
(AURA)
Rating:Informative Buy
Date:Nov 09, 2023 - Nov 09, 2024
Return:+44.50%
The most profitable trade made by David Michael Johnson

David Michael Johnson's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Zentalis Pharmaceuticals
Jun 21, 2024
Director
Uninformative Buy
$763.56K
Aura Biosciences Inc
Jun 24, 2024
Director
Uninformative Buy
$4.74M
List of latest transactions for each holding click on a transaction to see David Michael Johnson's performance on stock

David Michael Johnson insider profile FAQ

What is the percentage of profitable transactions made by David Michael Johnson?
The percentage of profitable transactions made by David Michael Johnson is 14%.
    What is the average return per transaction made by David Michael Johnson?
    The average return per transaction made by David Michael Johnson is -11.90%.
      What stocks does David Michael Johnson hold?
      David Michael Johnson holds: ZNTL, AURA stocks.
        What was David Michael Johnson’s latest transaction?
        David Michael Johnson latest transaction was an Uninformative Buy of ―.
          What was David Michael Johnson's most profitable transaction?
          David Michael Johnson’s most profitable transaction was an Informative Buy of AURA stock on November 9, 2023. The return on the trade was 44.50%.
            What is David Michael Johnson's role in Zentalis Pharmaceuticals?
            David Michael Johnson's role in Zentalis Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.